Insud Pharma
Zuleyha Aygun has extensive work experience in the pharmaceutical industry, primarily focused on quality assurance and compliance. Zuleyha is currently serving as the Quality Systems & Compliance Director at Insud Pharma since September 2021. Prior to this, they spent almost a decade at Exeltis Turkey, where they held various roles including Quality Assurance Manager and Qualified Person, Quality Assurance Assistant Manager, and Senior Quality Assurance Specialist. Before joining Exeltis Turkey, Zuleyha worked at The BirgiMefar Group as a Validation Personnel, Senior Quality Control Analyst, and in New Product and GMP Management. Zuleyha also has academic experience as an Academician at Abant İzzet Baysal Üniversitesi from 2006 to 2008.
Zuleyha Aygun received their Bachelor's degree in Chemistry from Abant İzzet Baysal Üniversitesi from 2000 to 2005. Zuleyha then pursued a Master's degree in Chemistry from the same university, graduating in 2008.
Insud Pharma
5 followers
INSUD PHARMA operates across the entire pharmaceutical value chain, delivering specialized expertise and experience in scientific research, development, manufacturing, sales and marketing of a wide range of value-adding active pharmaceutical ingredients (APIs), finished dosage forms (FDFs) and branded pharmaceuticals, for human and animal health. While the main offices are located in Madrid, Lugano, Buenos Aires, INSUD PHARMA is acting worldwide, creating a broad and balanced manufacturing and commercial network across Europe, America, Asia and Africa, to address global opportunities and customers` needs in all major pharmaceutical markets. INSUD PHARMA's activity is organized in three synergistic business areas: Industrial (Chemo), Branded (Exeltis) and Biotech (mAbxience), with over 7,300 professionals in more than 50 countries, 18 state-of-the-art facilities, 15 specialized R&D centers, 12 commercial offices and more than 35 pharmaceutical affiliates, serving 1,150 customers in 96 countries around the world. INSUD PHARMA believes in innovation and sustainable development. Our commitment is to improve people`s health and quality of life, providing access to quality medicines at affordable prices, and to continuously expand our efforts and R&D investment to develop new and better therapies.